Literature DB >> 10554534

[Low T3 syndrome in multiple trauma patients--a phenomenon or important pathogenetic factor?].

J U Schilling1, T Zimmermann, S Albrecht, H Zwipp, H D Saeger.   

Abstract

BACKGROUND: Many nonthyroidal illnesses, such as major trauma, severe burn injury, sepsis or immune deficiency are associated with a reduced T3 concentration without increased serum TSH secretion. The pathopysiologic meaning of this phenomenon was controversely discussed since its investigation 20 years ago. The identification of the Type I 5-iodthyronine-deiodinase as a selenoenzyme brought many new aspects into this discussion. PATIENTS AND METHODS: To investigate the correlation of T3 blood levels and the selenium concentrations in consideration of the severity of the nonthyroidal illness 20 patients with major trauma where included in this study. In all these patients frequently T3, T4, fT3, fT4, TSH, Se (whole blood), Se (plasma) and Glasgow-Coma-Scale (GCS), APACHE II and MOF-Score where measured until the 28th day of illness.
RESULTS: Five patients (20%) died during the study until the 8th day of measurement. Survivors and nonsurvivors initial showed a low T3 and fT3 level in serum. While the T3 serum concentrations of nonsurvivors remained on a low level the thyronine concentrations of survivors distinctly increased. The measured thyroid hormone concentrations were significantly correlated with MOF-score, APACHE II and inversely with GCS. There was no significant correlation between low T3/fT3 blood levels and low selenium concentrations in all observed patients.
CONCLUSION: The selenium deficiency in all patients with major trauma seems to be not the single cause of the low T3 syndrome. The distinctly suppression of TSH could be caused by the action of various cytokines such as IL-6 and TNF-alpha. Further investigations should improve the effectivity of substitution of selenium and/or thyroid hormones in the therapy of patients with severe nonthyroidal illness.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10554534     DOI: 10.1007/bf03042196

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  13 in total

1.  Identification of type I iodothyronine 5'-deiodinase as a selenoenzyme.

Authors:  D Behne; A Kyriakopoulos; H Meinhold; J Köhrle
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

Review 2.  The use of thyroid hormone in cardiac surgery.

Authors:  C Dyke
Journal:  Curr Opin Cardiol       Date:  1996-11       Impact factor: 2.161

Review 3.  Thyroid hormone deiodinases--a selenoenzyme family acting as gate keepers to thyroid hormone action.

Authors:  J Köhrle
Journal:  Acta Med Austriaca       Date:  1996

4.  Relations between the selenium status and the low T3 syndrome after major trauma.

Authors:  M M Berger; T Lemarchand-Béraud; C Cavadini; R Chioléro
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

5.  Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness.

Authors:  P H Davies; E G Black; M C Sheppard; J A Franklyn
Journal:  Clin Endocrinol (Oxf)       Date:  1996-02       Impact factor: 3.478

6.  Triiodothyronine resuscitates the impaired liver function after Pringle's maneuver.

Authors:  S Okamoto; K Nagamatsu; A Tokuka; D Manaka; A Tanaka; T Shimabukuro; M Ueda; Y Yamaoka
Journal:  Arch Surg       Date:  1994-08

7.  Association between serum interleukin-6 and serum 3,5,3'-triiodothyronine in nonthyroidal illness.

Authors:  A Boelen; M C Platvoet-Ter Schiphorst; W M Wiersinga
Journal:  J Clin Endocrinol Metab       Date:  1993-12       Impact factor: 5.958

Review 8.  Selenium supply regulates thyroid function, thyroid hormone synthesis and metabolism by altering the expression of the selenoenzymes Type I 5'-deiodinase and glutathione peroxidase.

Authors:  J Köhrle; M Oertel; M Gross
Journal:  Thyroidology       Date:  1992-04

9.  Type I iodothyronine deiodinase is a selenocysteine-containing enzyme.

Authors:  M J Berry; L Banu; P R Larsen
Journal:  Nature       Date:  1991-01-31       Impact factor: 49.962

10.  Effect of tumor necrosis factor on growth and function in FRTL5 cells.

Authors:  N A Patwardhan; A Lombardi
Journal:  Surgery       Date:  1991-12       Impact factor: 3.982

View more
  4 in total

1.  Correlation of low-T3 syndrome with blepharospasm and hemifacial spasm.

Authors:  Nami Nishikiori; Masahiro Ohba; Hajime Osanai
Journal:  Jpn J Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 2.447

Review 2.  Clinical review: thyroid hormone replacement in children after cardiac surgery--is it worth a try?

Authors:  Nikolaus A Haas; Christoph K Camphausen; Deniz Kececioglu
Journal:  Crit Care       Date:  2006-05-23       Impact factor: 9.097

3.  Low T3 syndrome is a strong predictor of poor outcomes in patients with community-acquired pneumonia.

Authors:  Jinliang Liu; Xuejie Wu; Fang Lu; Lifang Zhao; Lingxian Shi; Feng Xu
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

4.  Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.

Authors:  Salvatore Sciacchitano; Claudia De Vitis; Michela D'Ascanio; Simonetta Giovagnoli; Chiara De Dominicis; Andrea Laghi; Paolo Anibaldi; Andrea Petrucca; Gerardo Salerno; Iolanda Santino; Rachele Amodeo; Maurizio Simmaco; Christian Napoli; Agostino Tafuri; Arianna Di Napoli; Andrea Sacconi; Valentina Salvati; Gennaro Ciliberto; Maurizio Fanciulli; Giulia Piaggio; Luisa de Latouliere; Alberto Ricci; Rita Mancini
Journal:  J Transl Med       Date:  2021-04-01       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.